These diseases show a complex pathogenesis, best demonstrated in SLE, involving abnormalities in innate immune cells, loss of T- and B-cell tolerance, autoantibody production, and abnormalities in the nuclear factor kappa B (NFkB) and interferon pathways (IFN) (40–42). The gene discussed is IFNA1; the disease is systemic lupus erythematosus.